Abstract
We have established a Noble rat model to explore the mechanisms of hormonal mammary carcinogenesis, in which the role of androgen in promoting mammary carcinogenesis was highlighted. We have also established that stromal-epithelial interactions may be responsible for the promotional effects of testosterone in mammary carcinogenesis. Based on these understandings, in the present study we examined the expression of Bcl-2 and Bax in pre-malignant mammary glands from rats treated with different protocols of sex hormones for 7 weeks as well as sex hormone induced mammary tumours. We observed that Bcl-2 was strongly expressed in most of mammary tumour cells, whereas weak or negative in adjacent normal or hyperplastic ductal structures. On the contrary, Bax immunoreactivity was weak in mammary tumour cells while strongly expressed in adjacent normal or hyperplastic ductal structures. More importantly, the results from comparative study of ‘pre-malignant’ glands further showed that when animals were treated with 17β-oestradiol, the mammary epithelial cells expressed high levels of Bcl-2. The results from rats treated with testosterone, either alone or in combination with oestrogen, give rise to high levels of Bax expression in ‘pre-malignant’ mammary glands. These observations indicate that in ‘pre-malignant’ mammary glands, treatment with testosterone, either alone or in combination with 17β-oestradiol, may induce high apoptotic activities. However, in fully developed mammary tumours, the apoptotic activities apparently decrease in tumour cells. TUNEL assay provides further data to support this conclusion. Our study, thus, suggests that androgens may play a promoting role in mammary carcinogenesis by upregulation of Bax expression and induction of high apoptotic activities in ‘pre-malignant’ stage, which would provide a selective pressure favouring the expansion of the initiated cells.
Similar content being viewed by others
References
Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics 1997. CA Cancer J Clin 47: 5–27, 1997
Boyle P: Epidemiology of breast cancer. Bailliere's Clin Oncol 2: 1–8, 1998
Dickson RB, Lippman ME: Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev 8: 29–43, 1987
Horwitz KB, McGuire WL: Nuclear mechanism of estrogen action. Effect of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. J Biol Chem 253: 8185–8191, 1978
Rochefort H, Garcia M: The estrogenic and antiestrogenic activities of androgens in female target tissues. Pharmacol Ther 23: 193–216, 1983
Kesey JL: Breast cancer epidemiology: summary and future directions. Epidemiol Rev 15: 256–263, 1993
Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, Pisani P, Panico S, Secreto G: Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 88: 291–296, 1996
Secreto G, Toniolo P, Berrino F, Recchine C, Cavalleri A, Pisani P, Totis A, Fariselli G, DiPietro S: Serum and urinary androgens and risk of breast cancer in postmanopausal women. Cancer Res 51: 2572–2576, 1991
Secreto G, Toniolo P, Berrino F, Recchione C, DiPietro S, Fariselli G, Decarli A: Increased androgen activity and breast cancer risk in premanopausal women. Cancer Res 44: 5902–5905, 1984
Veronesi U, Pizzocaro G: Breast cancer in women subsequent to cystic disease of the breast. Surg Gynecol Obstet 126: 529–532, 1968
Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, Kahle L, Campbell WS, Tangrea JA, Schatzkin A: Serum sex hormone levels are related to breast cancer risk in postmenopausal women. Environ Health Perspectives 105(Suppl): 583–585, 1997
Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller P, Franz C: Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev 5: 533–539, 1996
Ruizeveld de Winter JA, Trapman J, Vermey M, Mulder E, Zegers ND, van der Kwast TH: Androgen receptor expression in human tissues: an immunohistochemical study. J Histochem Cytochem 39: 927, 1991
Janssen PJ, Brinkmann AO, Boersma WJ, van der Kwast TH: Immunohistochemical detection of the androgen receptor with monoclonal antibody F39.4 in rountinely processed, paraffin-embedded human tissues after microwave pre-treatment. J Histochem Cytochem 42: 1169–1175, 1994
Kimura N, Mizokami A: Immunocytochemical localization of androgen receptors with polyclonal antibody in paraffinembedded human tissues. J Histochem Cytochem 42: 126, 1994
Lea OA, Kvinnsland S, Thorsen T: Improved measurement of androgen receptors in human breast cancer. Cancer Res 49: 7162–7167, 1989
Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ: Androgen receptors in breast cancer. Cancer 54: 2436–2440, 1984
Soreide JA, Lea OA, Varhaug JE, Skarstein A, Kvinnsland S: Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlation to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. Eur J Surg Oncol 18: 112–118, 1992
Coleman WB, Tsongalis GJ: Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation. Clin Chem 41: 644–657, 1995
Krajewski S, Krajewski M, Shabaik A, Miyashita T, Wang HG, Reed JC: Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2. Am J Pathol 145: 1323–1336, 1994
Lu PJ, Lu QL, Rughetti A, Taylor-Papadimitriou J: bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. J Cell Biol 129: 1363–1378, 1995
Schwarze MMK, Hawley RG: Prevention of myeloma cell apoptosis by ectopic expression of bcl-2 or inter leukin 6-mediated upregulation of bcl-XL. Cancer Res 55: 2262–2265, 1995
Hockenbery DM: bcl-2 in cancer: development and apoptosis. J Cell Sci 107: 51–55, 1994
Reed JC: bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1–6, 1994
Steller H: Mechanisms and genes of cellular suicide. Science 267: 1445–1449, 1995
Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates cell death. Cell 74: 609–619, 1993
Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ: Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80: 285–291, 1995
Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB, Korsmeyer SJ: Multiple Bcl–2 family members demonstrate selective dimerixation with Bax. Proc Natl Acad Sci USA 92: 7834–7838, 1995
Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L, Wang HG, Reed JC: Interaction among members of the Bcl–2 protein family analyzed with the yeast two-hybrid system. Proc Natl Acad Sci USA 91: 9238–9242, 1994
Oltvai ZN, Korsmeyer SJ: Checkpoints of dueling dimers foil death wishes. Cell 79: 189–192, 1994
Lu Q, Abel P, Foster CS, Lalani E: bcl-2: Role in epithelial differentiation and oncogenesis. Hum Pathol 27: 102–110, 1996
Sabourin JC, Martin A, Baruch J, Truc JB, Gompel A, Poitout P: bcl-2 expression in normal breast tissue during the menstrual cycle. Int J Cancer 59: 1–6, 1994
Wong YC, Xie B, Tsao SW: 1999 Induction of breast cancer in Noble rats with a combination of estrogen and testosterone. In: Li JJ, Daling J, Li SA (eds) Hormonal Carcinogenesis, vol. 3, Springer-Verlag (in press)
Xie B, Tsao SW, Wong YC: Induction of high incidence of mammary tumor in female Noble rats with a combination of 17b-oestradiol and testosterone. Carcinogenesis 20: 1069–1078, 1999
Liao DJ, Hou X, Pantazis C, Bai S, Li SA, Li JJ: Combined treatment of estrogen and androgen is more effective than estrogen alone in induction of mammary adenocarcinoma in the male Noble rat. Am Asso Cancer Res 39: 387, 1998
Liao DJ, Pantazis CG, Hou X, Li SA: Promotion of estrogeninduced mammary gland carcinogenesis by androgen in the male Noble rat: Probable mediation by steroid receptor. Carcinogenesis 19: 2173–2180, 1998
Rosen PP: Rosen's breast pathology. Lippincott-Raven, New York, 1997
Jacobs TW, Prioleau JE, Stillman IE, Schnitt SJ: Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 88: 1054–1059, 1996
Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493–501, 1992
SPSS: SPSS Base 7.0 for Windows User's Guide. SPSS Inc., Chicago, IL, 1996
Xie B, Tsao SW, Wong YC: Sex hormone-induced mammary carcinogenesis in female Noble rats: the role of androgens. Carcinogenesis 20: 1597–1606, 1999
van Slooten HJ, van de Vijver MJ, van de Velde CJ, van Dierendock JH: Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity. Br J Cancer 77: 789–796, 1998
Binder C, Marx D, Binder L, Schauer A, Hiddemann W: Expression of Bax in relation to Bcl-2 and other predictive parameters in breast cancer. Ann Oncol 7: 129–133, 1996
Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3: 614–620, 1997
Teixeira C, Reed JC, Pratt MA: Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res 55: 3902–3907, 1995
Huang Y, Ray S, Reed JC, Ibrado AM, Tang C, Nawabi A, Bhalla K: Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MDF-7 cells. Breast Cancer Res Treat 42: 73–81, 1997
Lapointe J, Fournier A, Richard V, Labrie C: Androgens down-regulate bcl-2 protooncogene expression in ZR-75-1 human breast cancer cells. Endocrinology 140: 416–421, 1999
Shen KL, Harn HJ, Ho L, Yu CP, Chiu SC, Lee WH: The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labeling and 57 terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling. Cancer 82: 2373–2381, 1998
Akhurst RJ, Balmain A: Genetic events and the role of TGFb in epithelial tumor progression. J Pathol 187: 82–90, 1999
Rights and permissions
About this article
Cite this article
Xie, B., Tsao, S. & Wong, Y. Sex hormone-induced mammary carcinogenesis in the female Noble rats: Expression of Bcl-2 and Bax in hormonal mammary carcinogenesis. Breast Cancer Res Treat 61, 45–57 (2000). https://doi.org/10.1023/A:1006400732154
Issue Date:
DOI: https://doi.org/10.1023/A:1006400732154